IKT Inhibikase Therapeutics, Inc. - Common Stock
$1,63
Prix · Mai 20, 2026
Données fondamentales au Mai 12, 2026
Fourchette 52 semaines
$1–$2
32% of range
Note des analystes
BUY
11 analysts
Objectif de cours
$6
+268% upside
P/E (TTM)
-4.2
ROE
-38.2%
Marge nette
-1299.0%
IKT Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$1.63
Capitalisation Boursière
$270M
P/E (TTM)
-4.2
BPA (TTM)
$-0.49
Revenus (TTM)
$0
Rendement div.
—
ROE
-38.2%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $2
IKT Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2020-12-31
→
2024-12-31
BPA
$-0.49
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-28M
2023-12-31
→
2025-12-31
Marges
-1299.0%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
IKT
Médiane des pairs
P/E (TTM)
-4.2
2.4
P/B
1.6
1.4
Price / FCF (Cours / FCF)
-9.7
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
IKT
Médiane des pairs
Operating Margin (Marge d'exploitation)
-1399.0%
—
Net Profit Margin (Marge nette)
-1299.0%
-946.2%
ROA
-34.5%
-52.8%
ROE
-38.2%
-60.2%
ROIC
-30.1%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
IKT
Médiane des pairs
Current Ratio (Ratio de liquidité)
21.7
7.4
Quick Ratio (Ratio de liquidité réduite)
26.3
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
IKT
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
111.0%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-28.0%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
IKT
Médiane des pairs
IKT Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
11 analystes
- Achat fort 3 27,3%
- Achat 7 63,6%
- Conserver 1 9,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
7 analystes · 2026-05-18
Médiane
$6.00
← En dessous de tous les objectifs
$1.63
Bas
$3.00
Haut
$8.00
Objectif médian
$6.00
+268,1%
Objectif moyen
$6.00
+268,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.08%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.10 | $-0.11 | 0.01% |
| 31 décembre 2025 | $-0.09 | $-0.10 | 0.01% |
| 30 septembre 2025 | $-0.13 | $-0.13 | 0.00% |
| 30 juin 2025 | $-0.11 | $-0.09 | -0.02% |
| 31 mars 2025 | $-0.17 | $-0.11 | -0.06% |
| 31 décembre 2024 | $-0.50 | $-0.09 | -0.41% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| BDTX | $139M | 6.2 | — | 31.9% | 18.3% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $260.5K | $123.4K | $3M | $698.5K | |
| R&D Expense | $30M | $17M | $14M | $12M | $11M | $893.8K | |
| SG&A Expense | $24M | $11M | $7M | $6M | $7M | $3M | |
| Operating Expenses | $52M | $29M | $20M | $18M | $18M | $4M | |
| Operating Income | $-52M | $-29M | $-20M | $-18M | $-15M | $-3M | |
| Interest Expense | · | · | · | · | $19.9K | $29.4K | |
| Pretax Income | $-48.3K | $-27.5K | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-48M | $-28M | $-19M | $-18M | $-15M | $-3M | |
| EPS (Basic) | $-0.49 | $-1.16 | $-3.16 | $-4.28 | $-0.81 | · | |
| EPS (Diluted) | $-0.49 | $-1.16 | $-3.16 | $-4.28 | $-0.81 | · | |
| Shares (Basic) | 98,310,190 | 23,712,220 | 6,028,210 | 4,223,099 | 18,209,198 | · | |
| Shares (Diluted) | 98,310,190 | 23,712,220 | 6,028,210 | 4,223,099 | 18,209,198 | · | |
| EBITDA | $-52M | · | $-20M | · | $-15M | · |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $98M | $9M | $7M | $41M | $14M | |
| Short-term Investments | $40M | $41M | $4M | $16M | $0 | · | |
| Prepaid Expense | $343.4K | $826.5K | $739.2K | $163.5K | $2M | $54.8K | |
| Current Assets | $180M | $98M | $14M | $24M | $42M | $15M | |
| PP&E (Net) | $0 | $47.1K | $73.4K | $236.5K | $0 | · | |
| PP&E (Gross) | $0 | $103.8K | $103.8K | $243.3K | · | · | |
| Other Non-current Assets | $95.1K | $0 | · | · | · | · | |
| Total Assets | $181M | $99M | $15M | $25M | $42M | $15M | |
| Accounts Payable | $1M | $943.0K | $646.8K | $1M | $1M | $2M | |
| Accrued Liabilities | $4M | $3M | $2M | $2M | $3M | $632.9K | |
| Short-term Debt | · | · | · | · | $248.9K | $42.5K | |
| Current Liabilities | $8M | $4M | $3M | $4M | $4M | $5M | |
| Capital Leases | · | · | $90.1K | $205.5K | $0 | · | |
| Total Liabilities | $8M | $4M | $4M | $4M | $4M | $5M | |
| Long-term Debt | · | · | $381.8K | · | $248.9K | · | |
| Total Debt | · | · | · | · | $248.9K | · | |
| Common Stock | $131.7K | $69.4K | $6.2K | $4.2K | $25.2K | $10.1K | |
| Retained Earnings | $-143M | $-94M | $-67M | $-48M | $-30M | $15M | |
| AOCI | $21.8K | $-37.2K | $877 | $104.7K | $0 | · | |
| Stockholders' Equity | $173M | $95M | $11M | $21M | $38M | $10M | |
| Liabilities + Equity | $181M | $99M | $15M | $25M | $42M | $15M | |
| Shares Outstanding | 131,691,237 | 69,362,439 | 6,186,280 | 4,224,294 | 4,212,317 | 10,050,849 |
Flux de trésorerie 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $15M | $8M | $500.1K | $458.1K | $2M | $573.7K | |
| Operating Cash Flow | $-28M | $-19M | $-18M | $-17M | $-14M | $-1M | |
| CapEx | $13.4K | $0 | $14.2K | $243.3K | $0 | · | |
| Investing Cash Flow | $2M | $-37M | $12M | $-16M | $0 | · | |
| Stock Issued | $108M | $103M | $9M | $0 | $0 | $4.9K | |
| Net Stock Activity | $108M | · | $9M | · | $0 | · | |
| Financing Cash Flow | $108M | $103M | $8M | $-204.8K | $41M | $15M | |
| Free Cash Flow | $-28M | · | $-18M | · | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1399.0% | · | -7712.0% | · | -476.2% | · | |
| Net Margin | -1299.0% | · | -7304.7% | · | -476.9% | · | |
| Pretax Margin | -1.3% | · | · | · | · | · | |
| EBITDA Margin | -1399.0% | · | -7712.0% | · | -476.2% | · | |
| ROA | -34.5% | · | -96.5% | · | -51.6% | · | |
| ROE | -38.2% | · | -146.4% | · | -36.2% | · | |
| ROIC | -30.1% | · | · | · | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | · | 4.1 | · | · | · | |
| Quick Ratio | 26.3 | · | 3.9 | · | 10.1 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| Interest Coverage | · | · | · | · | -741.2 | · |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · | 0.1 | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 111.0% | -96.0% | 343.9% | · | |
| Revenue CAGR 3Y | · | · | -28.0% | · | · | · |
Valorisation (TTM) 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $260.5K | $123.4K | $3M | $698.5K | |
| Net Income TTM | $-48M | $-28M | $-19M | $-18M | $-15M | $-3M | |
| Market Cap | $270M | · | $8M | · | $222M | · | |
| Enterprise Value | · | · | · | · | $181M | · | |
| P/E | -4.2 | -2.8 | -0.4 | -0.7 | -10.9 | · | |
| P/S | · | · | 30.2 | · | 71.6 | · | |
| P/B | 1.6 | · | 0.7 | · | 5.8 | · | |
| P / Tangible Book | 1.6 | 2.4 | 0.7 | 3.6 | 5.8 | · | |
| P / Cash Flow | -9.7 | · | -0.4 | · | -15.5 | · | |
| P / FCF | -9.7 | · | -0.4 | · | · | · | |
| EV / EBITDA | · | · | · | · | -12.3 | · | |
| EV / Revenue | · | · | · | · | 58.5 | · | |
| Earnings Yield | -23.9% | -35.7% | -248.8% | -142.7% | -9.2% | · |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $1 | $79.6K | $116.4K | $64.5K | $63.6K | $7.3K | $6.6K | |
| R&D Expense | $11M | $6M | $8M | $5M | $11M | $7M | $4M | $3M | $3M | $3M | $3M | $5M | $3M | $3M | $3M | $3M | |
| SG&A Expense | $7M | $7M | $6M | $6M | $5M | $6M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | |
| Operating Expenses | $18M | $14M | $13M | $11M | $15M | $13M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | $4M | $5M | $5M | |
| Operating Income | $-18M | $-14M | $-13M | $-11M | $-15M | $-13M | $-6M | $-5M | $-5M | $-4M | $-5M | $-6M | $-5M | $-4M | $-5M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income | $-16M | $-13M | $-12M | $-10M | $-14M | $-12M | $-6M | $-5M | $-5M | $-4M | $-5M | $-6M | $-4M | $-4M | $-4M | $-5M | |
| EPS (Basic) | $-0.10 | $-0.10 | $-0.13 | $-0.11 | $-0.15 | $0.88 | $-0.65 | $-0.66 | $-0.73 | $-0.21 | $-0.86 | $-1.11 | $-0.98 | $-1.94 | $-1.06 | $-1.10 | |
| EPS (Diluted) | $-0.10 | $-0.10 | $-0.13 | $-0.11 | $-0.15 | $0.88 | $-0.65 | $-0.66 | $-0.73 | $-0.21 | $-0.86 | $-1.11 | $-0.98 | $-1.94 | $-1.06 | $-1.10 | |
| Shares (Basic) | 172,306,932 | -171,287,579 | 90,050,973 | 90,009,625 | 89,537,171 | 953,286 | 8,882,570 | 7,535,667 | 6,340,697 | -9,125,241 | 5,342,337 | 5,226,101 | 4,585,013 | -29,430,943 | 4,224,294 | 4,224,294 | |
| Shares (Diluted) | 172,306,932 | -171,287,579 | 90,050,973 | 90,009,625 | 89,537,171 | 953,286 | 8,882,570 | 7,535,667 | 6,340,697 | -9,125,241 | 5,342,337 | 5,226,101 | 4,585,013 | -29,430,943 | 4,224,294 | 4,224,294 | |
| EBITDA | $-18M | · | $-13M | $-11M | $-15M | · | $-6M | $-5M | $-5M | · | $-5M | $-6M | $-5M | · | $-5M | $-5M |
Bilan 22
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $179M | $38M | $78M | $73M | $98M | $913.4K | $3M | $2M | $9M | $15M | $2M | $4M | $7M | $6M | $32M | |
| Short-term Investments | $121M | $40M | $39M | $10M | $20M | $41M | $2M | $5M | $7M | $4M | $2M | $19M | $22M | $16M | $21M | · | |
| Prepaid Expense | $1M | $343.4K | $618.8K | $682.6K | $932.0K | $826.5K | $280.9K | $356.5K | $851.1K | $739.2K | $371.5K | $543.9K | $922.8K | $163.5K | $505.9K | $811.5K | |
| Current Assets | $172M | $180M | $79M | $89M | $94M | $98M | $4M | $9M | $11M | $14M | $18M | $22M | $28M | $24M | $28M | $34M | |
| PP&E (Net) | · | $0 | $0 | $23.7K | $47.8K | $47.1K | $53.7K | $60.2K | $66.8K | $73.4K | $79.9K | $86.5K | $231.5K | $236.5K | $241.6K | $43.1K | |
| PP&E (Gross) | · | $0 | $117.2K | $117.2K | $117.2K | $103.8K | $103.8K | $103.8K | $103.8K | $103.8K | $103.8K | $257.5K | $243.3K | $243.3K | $243.3K | · | |
| Other Non-current Assets | $155.8K | $95.1K | $57.9K | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $173M | $181M | $80M | $89M | $94M | $99M | $4M | $9M | $11M | $15M | $18M | $22M | $28M | $25M | $29M | $34M | |
| Accounts Payable | $2M | $1M | $620.5K | $3M | $2M | $943.0K | $3M | $1M | $1M | $646.8K | $734.6K | $754.1K | $959.1K | $1M | $781.2K | $860.4K | |
| Accrued Liabilities | $4M | $4M | $4M | $3M | $4M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Current Liabilities | $6M | $8M | $7M | $9M | $9M | $4M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | · | |
| Capital Leases | · | · | · | · | · | · | · | $25.6K | $58.3K | · | $121.0K | $150.0K | $178.1K | $205.5K | $232.0K | · | |
| Other Non-current Liabilities | $400.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $8M | $7M | $9M | $9M | $4M | $5M | $4M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $4M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Common Stock | $132.0K | $131.7K | $74.8K | $74.5K | $74.3K | $69.4K | $7.5K | $7.2K | $6.5K | $6.2K | $5.4K | $5.3K | $31.1K | $4.2K | $25.2K | $25.2K | |
| Retained Earnings | $-159M | $-143M | $-130M | $-118M | $-108M | $-94M | $-82M | $-77M | $-72M | $-67M | $-63M | $-58M | $-52M | $-48M | $-44M | $-39M | |
| AOCI | $-26.3K | $21.8K | $-4.2K | $-2.9K | $-967 | $-37.2K | $1.8K | $-1.0K | $-1.8K | $877 | $-143 | $-1.7K | $165.8K | $104.7K | $26.8K | · | |
| Stockholders' Equity | $168M | $173M | $73M | $80M | $86M | $95M | $-530.6K | $5M | $7M | $11M | $15M | $19M | $25M | $21M | $25M | $30M | |
| Liabilities + Equity | $173M | $181M | $80M | $89M | $94M | $99M | $4M | $9M | $11M | $15M | $18M | $22M | $28M | $25M | $29M | $34M | |
| Shares Outstanding | 132,032,636 | 131,691,237 | 74,807,911 | 74,516,635 | 74,341,540 | 69,362,439 | 7,464,070 | 7,216,145 | 6,476,844 | 6,186,280 | 5,360,326 | 5,290,826 | 31,056,238 | 4,224,294 | 25,227,051 | 25,227,051 |
Flux de trésorerie 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $5M | $4M | $2M | $8M | $148.0K | $30.7K | $53.4K | $122.2K | $129.8K | $124.8K | $123.3K | $100.4K | $101.8K | $132.8K | |
| Operating Cash Flow | $-12M | $-8M | $-11M | $-6M | $-4M | $-5M | $-5M | $-5M | $-4M | $-3M | $-4M | $-5M | $-6M | $-4M | $-6M | $-4M | |
| CapEx | $0 | $0 | $0 | $0 | $13.4K | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $200.2K | · | |
| Investing Cash Flow | $-80M | $-98.8K | $-29M | $10M | $21M | $-39M | $3M | $3M | $-3M | $-2M | $17M | $3M | $-6M | $5M | $-21M | $-43.1K | |
| Stock Issued | $3M | $108M | $0 | $150 | $0 | $100M | $182.0K | $3M | $397.6K | $452 | $70 | $-36.0K | $1M | $0 | $0 | $0 | |
| Net Stock Activity | $3M | · | · | · | $0 | · | · | · | $397.6K | · | · | · | $9M | · | · | · | |
| Financing Cash Flow | $3M | $109M | $-134.1K | $31.8K | $0 | $100M | $182.0K | $3M | $367.0K | $-138.1K | $70 | $-36.0K | $9M | $0 | $0 | $0 | |
| Free Cash Flow | $-12M | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · | · |
Rentabilité 5
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -5993.4% | -5328.1% | -7307.6% | · | -61899.6% | -70817.1% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -5775.1% | -4963.5% | -6940.0% | · | -61645.4% | -70817.1% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -5993.4% | -5328.1% | -7307.6% | · | -61899.6% | -70817.1% | |
| ROA | -12.2% | · | -28.4% | -20.3% | -26.0% | · | -51.9% | -31.8% | -23.7% | · | -19.8% | -20.5% | -13.5% | · | -12.1% | -11.2% | |
| ROE | -12.9% | · | -33.0% | -23.3% | -29.6% | · | -79.8% | -40.4% | -29.0% | · | -22.9% | -23.6% | -15.1% | · | -13.2% | -12.1% |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 30.1 | · | 11.7 | 10.1 | 11.0 | · | 0.9 | 2.3 | 2.6 | · | 6.4 | 8.0 | 10.4 | · | 8.7 | · | |
| Quick Ratio | 29.8 | · | 11.5 | 10.0 | 10.9 | · | 0.7 | 2.1 | 2.3 | · | 6.1 | 7.7 | 9.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Efficacité 1
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 |
Valorisation (TTM) 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $79.6K | $196.0K | $260.5K | · | $267.8K | $194.8K | $124.4K | · | $388.3K | $2M | |
| Net Income TTM | $-52M | · | $-41M | $-34M | $-29M | · | $-20M | $-20M | $-20M | · | $-19M | $-19M | $-18M | · | $-18M | $-16M | |
| Market Cap | $222M | · | $121M | $145M | $163M | · | $10M | $9M | $14M | · | $7M | $19M | $123M | · | $138M | $112M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $111M | $80M | |
| P/E | -3.4 | · | -1.6 | -1.2 | -1.0 | · | -0.4 | -0.4 | -0.6 | · | -0.3 | -0.8 | -1.2 | · | -2.2 | -2.7 | |
| P/S | · | · | · | · | · | · | 121.9 | 44.6 | 53.7 | · | 27.8 | 98.1 | 985.7 | · | 354.7 | 64.5 | |
| P/B | 1.3 | · | 1.7 | 1.8 | 1.9 | · | -18.3 | 1.7 | 2.1 | · | 0.5 | 1.0 | 4.8 | · | 5.5 | 3.8 | |
| P / Tangible Book | 1.3 | · | 1.7 | 1.8 | 1.9 | · | · | 1.7 | 2.1 | · | 0.5 | 1.0 | 4.8 | · | 5.5 | 3.8 | |
| P / Cash Flow | -18.4 | · | · | · | -39.7 | · | · | · | -3.6 | · | · | · | -20.5 | · | · | · | |
| P / FCF | -18.4 | · | · | · | -39.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -24.6 | -17.3 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 286.4 | 46.0 | |
| Earnings Yield | -29.2% | · | -64.2% | -80.5% | -100.0% | · | -223.1% | -277.7% | -170.4% | · | -288.5% | -117.7% | -84.1% | · | -46.2% | -37.7% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | — | $0 | $260.5K | $123.4K | $3M |
| Marge d'exploitation % | -1399.0% | — | -7712.0% | — | -476.2% |
| Résultat net | $-48M | $-28M | $-19M | $-18M | $-15M |
| BPA dilué | $-0.49 | $-1.16 | $-3.16 | $-4.28 | $-0.81 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | — | — | — | 0.0 |
| Ratio de liquidité | 21.7 | — | 4.1 | — | — |
| Ratio de liquidité réduite | 26.3 | — | 3.9 | — | 10.1 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-28M | — | $-18M | — | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.